Outcomes in Adults With Acute Liver Failure Between 1998 and 2013
Adrian Reuben(Medical University of South Carolina), William M. Lee(The University of Texas Southwestern Medical Center), Jeffrey S. Crippin(Washington University in St. Louis), Averell H. Sherker(National Institutes of Health), A. James Hanje(Washington University Medical Center), Brendan M. McGuire(University of Alabama at Birmingham), Patricia R. Robuck(National Institute of Diabetes and Digestive and Kidney Diseases), Natalie Murray(Institute of Genetics), Raymond T. Chung(Harvard University), K. Rajender Reddy(Hospital of the University of Pennsylvania), Tarek Hassanein, Timothy M. McCashland(University of Nebraska–Lincoln), Constantine Karvellas(University of Alberta), Timothy J. Davern(California Pacific Medical Center), R. Todd Stravitz(Virginia Commonwealth University), Jody C. Olson(University of Kansas), Valerie Durkalski(Medical University of South Carolina), Robert J. Fontana(University of Michigan), Michael L. Schilsky(Yale University), Bilal Hameed(University of California, San Francisco), Lorenzo Rossaro(University of California Davis Medical Center), David Koch(Fraunhofer Institute for Manufacturing Engineering and Automation), Oren K. Fix(Swedish Medical Center), Anne M. Larson(University of Washington), Daniel Ganger(Northwestern University), Obaid S. Shaikh(University of Pittsburgh), Santiago J. Muñoz(Einstein Medical Center Philadelphia), Alastair D. Smith(Duke Medical Center), J. Eileen Hay(Mayo Clinic in Arizona), Atif Zaman, Iris Liou(University of Washington), Steven B. Han(University of California, Los Angeles), Raj Satyanarayana(Jacksonville College), Robert S. Brown(Washington University Medical Center), Holly Tillman(Medical University of South Carolina), Ram Subramanian(Emory University), M. Edwyn Harrison(Mayo Clinic in Arizona)
Cited by 383
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Liver biopsy†
|Hepatology|2008|1.9k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k